Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema.

Igor KozakIan PearceGemmy Cheung Chui MingTobias MachewitzGeorge N LambrouDaniel MolinaLima SuleimanHossam YoussefNeil M Bressler

Published in: Eye (London, England) (2023)

BCVA time in range may represent another way to describe visual outcomes and potential impact on vision-related functions over time for patients with DMO and provide a better understanding, for physicians and patients, of the consistency of treatment efficacy.

Keyphrases

end stage renal disease
primary care
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
metabolic syndrome
diabetic retinopathy
optical coherence tomography
insulin resistance
wound healing
patient reported
replacement therapy